PETMED EXPRESS INC
Financial highlights
| Metric | FY 03/31/25 | FY 03/31/24 | FY 03/31/23 | FY 03/31/22 | FY 03/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $227.0M | $274.1M | $247.6M | $272.3M | $303.6M |
| Cost of revenue | $157.8M | $189.3M | $171.1M | $195.3M | $219.3M |
| Gross profit | $69.1M | $84.8M | $76.5M | $76.9M | $84.3M |
| Operating expenses | $70.7M | $92.9M | $70.5M | $52.7M | $53.8M |
| Operating income | -$1.5M | -$8.2M | $6.1M | $24.3M | $30.5M |
| Pretax income | -$587,000 | -$6.3M | $7.4M | $24.2M | $30.9M |
| Income tax expense | $5.7M | $1.2M | $2.3M | $5.5M | $7.0M |
| Net income | -$6.3M | -$7.5M | $5.1M | $18.7M | $23.9M |
| Balance Sheet | |||||
| Cash and equivalents | $54.7M | $55.3M | $104.1M | $111.1M | $118.7M |
| Current assets | $78.9M | $93.6M | $130.4M | $151.0M | $161.2M |
| Total assets | $148.7M | $169.9M | $167.5M | $179.7M | $187.5M |
| Current liabilities | $62.8M | $72.2M | $57.5M | $56.2M | $44.9M |
| Total liabilities | $63.6M | $73.2M | $57.5M | $56.2M | $46.2M |
| Stockholders' equity | $85.1M | $96.7M | $110.0M | $123.5M | $124.9M |
| Cash Flow Statement | |||||
| Cash from operations | $4.7M | $4.3M | $27.8M | $18.5M | $40.1M |
| Depreciation and amortization | $7.0M | $7.1M | $3.5M | $2.7M | $2.4M |
| Stock-based compensation | $6.6M | $6.9M | $6.6M | $4.5M | $3.3M |
| Capital expenditure | $5.1M | $4.5M | $5.3M | $1.8M | $2.4M |
| Free cash flow | -$395,000 | -$194,000 | $22.5M | $16.7M | $37.6M |
| Dividends paid | $181,000 | $12.4M | $24.5M | $24.4M | $22.7M |
| Share repurchases | — | — | — | $0 | $0 |
| Impairments | $1.2M | $0 | $0 | — | — |
Shares outstanding 21.4M · Free float 72.6%
Annual filing data through FY ended March 31, 2025; float as of July 3, 2026.